These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia. Harding-Esch EM, Sillah A, Edwards T, Burr SE, Hart JD, Joof H, Laye M, Makalo P, Manjang A, Molina S, Sarr-Sissoho I, Quinn TC, Lietman T, Holland MJ, Mabey D, West SK, Bailey R, Partnership for Rapid Elimination of Trachoma (PRET) study group. PLoS Negl Trop Dis; 2013; 7(6):e2115. PubMed ID: 23785525 [Abstract] [Full Text] [Related]
5. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Burton MJ, Holland MJ, Faal N, Aryee EA, Alexander ND, Bah M, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL. Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4215-22. PubMed ID: 14507864 [Abstract] [Full Text] [Related]
6. Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020? Harding-Esch EM, Edwards T, Sillah A, Sarr I, Roberts CH, Snell P, Aryee E, Molina S, Holland MJ, Mabey DC, Bailey RL. PLoS Negl Trop Dis; 2009 Dec 22; 3(12):e573. PubMed ID: 20027217 [Abstract] [Full Text] [Related]
8. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL, Mabey DC. Lancet; 2005 Oct 08; 366(9493):1296-300. PubMed ID: 16214600 [Abstract] [Full Text] [Related]
9. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions. Biebesheimer JB, House J, Hong KC, Lakew T, Alemayehu W, Zhou Z, Moncada J, Rogér A, Keenan J, Gaynor BD, Schachter J, Lietman TM. Ophthalmology; 2009 Nov 08; 116(11):2047-50. PubMed ID: 19744717 [Abstract] [Full Text] [Related]
10. Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau. Last AR, Burr SE, Weiss HA, Harding-Esch EM, Cassama E, Nabicassa M, Mabey DC, Holland MJ, Bailey RL. PLoS Negl Trop Dis; 2014 Jun 08; 8(6):e2900. PubMed ID: 24967629 [Abstract] [Full Text] [Related]
11. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. West SK, Munoz B, Mkocha H, Gaydos C, Quinn T. Invest Ophthalmol Vis Sci; 2007 Apr 08; 48(4):1492-7. PubMed ID: 17389476 [Abstract] [Full Text] [Related]
12. Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial. Harding-Esch EM, Edwards T, Mkocha H, Munoz B, Holland MJ, Burr SE, Sillah A, Gaydos CA, Stare D, Mabey DC, Bailey RL, West SK, PRET Partnership. PLoS Negl Trop Dis; 2010 Nov 02; 4(11):e861. PubMed ID: 21072224 [Abstract] [Full Text] [Related]
13. Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania. Cajas-Monson LC, Mkocha H, Muñoz B, Quinn TC, Gaydos CA, West SK. PLoS Negl Trop Dis; 2011 Mar 15; 5(3):e978. PubMed ID: 21423645 [Abstract] [Full Text] [Related]
14. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification. Yang JL, Hong KC, Schachter J, Moncada J, Lekew T, House JI, Zhou Z, Neuwelt MD, Rutar T, Halfpenny C, Shah N, Whitcher JP, Lietman TM. Invest Ophthalmol Vis Sci; 2009 Jan 15; 50(1):90-4. PubMed ID: 18689701 [Abstract] [Full Text] [Related]
16. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children. Lee JS, Muñoz BE, Mkocha H, Gaydos CA, Quinn TC, West SK. PLoS Negl Trop Dis; 2014 Apr 15; 8(4):e2761. PubMed ID: 24722392 [Abstract] [Full Text] [Related]
17. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program. Pant BP, Bhatta RC, Chaudhary JS, Awasthi S, Mishra S, Sharma S, Cuddapah PA, Gwyn SE, Stoller NE, Martin DL, Keenan JD, Lietman TM, Gaynor BD. PLoS Negl Trop Dis; 2016 Feb 15; 10(2):e0004462. PubMed ID: 26871898 [Abstract] [Full Text] [Related]
18. Mass treatment with single-dose azithromycin for trachoma. Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC. N Engl J Med; 2004 Nov 04; 351(19):1962-71. PubMed ID: 15525721 [Abstract] [Full Text] [Related]
19. Trachoma and ocular Chlamydia trachomatis rates in children in trachoma-endemic communities enrolled for at least three years in the Tanzania National Trachoma Control Programme. Mkocha H, Munoz B, West S. Tanzan J Health Res; 2009 Jul 04; 11(3):103-10. PubMed ID: 20734706 [Abstract] [Full Text] [Related]
20. Community-level Association between Clinical Trachoma and Ocular Chlamydia Infection after MASS Azithromycin Distribution in a Mesoendemic Region of Niger. Amza A, Kadri B, Nassirou B, Cotter SY, Stoller NE, West SK, Bailey RL, Porco TC, Keenan JD, Lietman TM, Oldenburg CE. Ophthalmic Epidemiol; 2019 Aug 04; 26(4):231-237. PubMed ID: 30957594 [Abstract] [Full Text] [Related] Page: [Next] [New Search]